SAN MATEO, Kalifornien, 8. Oktober 2024 /PRNewswire/ – Selonterra, Inc. (www.selonterra.com), ein Biotechnologieunternehmen, das transformative Therapien für neurodegenerative Erkrankungen entwickelt, gibt eine zweite Förderzusage in Höhe von 2.500.000 US-Dollar von der Michael J. Fox…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.